Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye

Purpose: Dry eye disease (DED) is a common condition causing substantial burden. A randomized, controlled, single-masked study was performed in 40 patients with mild to moderate DED to evaluate the efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10 (CoQ1...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2018-01, Vol.28 (1), p.25-31
Main Authors: Postorino, Elisa I., Rania, Laura, Aragona, Emanuela, Mannucci, Carmen, Alibrandi, Angela, Calapai, Gioacchino, Puzzolo, Domenico, Aragona, Pasquale
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663
cites cdi_FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663
container_end_page 31
container_issue 1
container_start_page 25
container_title European journal of ophthalmology
container_volume 28
creator Postorino, Elisa I.
Rania, Laura
Aragona, Emanuela
Mannucci, Carmen
Alibrandi, Angela
Calapai, Gioacchino
Puzzolo, Domenico
Aragona, Pasquale
description Purpose: Dry eye disease (DED) is a common condition causing substantial burden. A randomized, controlled, single-masked study was performed in 40 patients with mild to moderate DED to evaluate the efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10 (CoQ10). Methods: Enrolled subjects were divided into 2 groups: group A, treated with XLHA + CoQ10; and group B, treated with hyaluronic acid (HA). Eyedrops were administered 4 times daily for 3 months. The Ocular Surface Disease Index (OSDI) questionnaire, tear break-up time (TBUT), corneal and conjunctival staining, and meibomian gland assessment (MGD) were evaluated; furthermore, corneal aesthesiometry, in vivo corneal confocal microscopy, visual acuity, intraocular pressure (IOP), and fundus examination were performed. Results: At the end of treatment, OSDI score significantly decreased in groups A and B (p
doi_str_mv 10.5301/ejo.5001011
format article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5301_ejo_5001011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.5301_ejo.5001011</sage_id><sourcerecordid>10.5301_ejo.5001011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663</originalsourceid><addsrcrecordid>eNptkMtKAzEUhoMoWKsrX-AsBZmaZCaZ6VJKvUBBBF0PaXLSpk6TkqTIuPLRnWqXrv6z-M7tI-Sa0YkoKbvDTZgIShll7ISMWM2rQlImT4eacVrImrNzcpHShlJOpxUfke-5tU4r3UOwgD2aGHYJdPBZOe_8CnQMKRWd8x9oYN2rbh-DdxqUdgaUNwOL_qvfIrwyCs5DjqjyoXM3BPqc4NPlNWxdZyAH2AaDUWUEE_vDwktyZlWX8OqYY_L-MH-bPRWLl8fn2f2i0GUjcmGtaLREYRojS26XQnArFJ9WFqvGLA2rayFKWWJtGa8sF5IZ2mjOG1sqJWU5Jrd_c38fimjbXXRbFfuW0fYgrx3ktUd5A33zRye1wnYT9tEPx_2L_gBXB3EH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye</title><source>Sage Journals Online</source><creator>Postorino, Elisa I. ; Rania, Laura ; Aragona, Emanuela ; Mannucci, Carmen ; Alibrandi, Angela ; Calapai, Gioacchino ; Puzzolo, Domenico ; Aragona, Pasquale</creator><creatorcontrib>Postorino, Elisa I. ; Rania, Laura ; Aragona, Emanuela ; Mannucci, Carmen ; Alibrandi, Angela ; Calapai, Gioacchino ; Puzzolo, Domenico ; Aragona, Pasquale</creatorcontrib><description>Purpose: Dry eye disease (DED) is a common condition causing substantial burden. A randomized, controlled, single-masked study was performed in 40 patients with mild to moderate DED to evaluate the efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10 (CoQ10). Methods: Enrolled subjects were divided into 2 groups: group A, treated with XLHA + CoQ10; and group B, treated with hyaluronic acid (HA). Eyedrops were administered 4 times daily for 3 months. The Ocular Surface Disease Index (OSDI) questionnaire, tear break-up time (TBUT), corneal and conjunctival staining, and meibomian gland assessment (MGD) were evaluated; furthermore, corneal aesthesiometry, in vivo corneal confocal microscopy, visual acuity, intraocular pressure (IOP), and fundus examination were performed. Results: At the end of treatment, OSDI score significantly decreased in groups A and B (p&lt;0.01 and p&lt;0.05, respectively); the decrease was significantly higher in group A. Corneal staining decreased in both groups, with lower scores in group A. The MGD was significantly ameliorated in group A patients. No differences were found for corneal aesthesiometry or TBUT. Epithelial cell reflectivity was significantly reduced only in group A. For keratocytes and stromal matrix parameters, there was a significant improvement in group A. No changes were found for visual acuity, IOP, or fundus examination. Conclusions: The XLHA + CoQ10 treatment showed greater effectiveness in DED compared to HA alone, probably due to the longer permanency on ocular surface and the antioxidant activity of CoQ10. Therefore, XLHA + CoQ10 eyedrops could represent a new possibility in dry eye treatment.</description><identifier>ISSN: 1120-6721</identifier><identifier>EISSN: 1724-6016</identifier><identifier>DOI: 10.5301/ejo.5001011</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>European journal of ophthalmology, 2018-01, Vol.28 (1), p.25-31</ispartof><rights>The Author(s) 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663</citedby><cites>FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids></links><search><creatorcontrib>Postorino, Elisa I.</creatorcontrib><creatorcontrib>Rania, Laura</creatorcontrib><creatorcontrib>Aragona, Emanuela</creatorcontrib><creatorcontrib>Mannucci, Carmen</creatorcontrib><creatorcontrib>Alibrandi, Angela</creatorcontrib><creatorcontrib>Calapai, Gioacchino</creatorcontrib><creatorcontrib>Puzzolo, Domenico</creatorcontrib><creatorcontrib>Aragona, Pasquale</creatorcontrib><title>Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye</title><title>European journal of ophthalmology</title><description>Purpose: Dry eye disease (DED) is a common condition causing substantial burden. A randomized, controlled, single-masked study was performed in 40 patients with mild to moderate DED to evaluate the efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10 (CoQ10). Methods: Enrolled subjects were divided into 2 groups: group A, treated with XLHA + CoQ10; and group B, treated with hyaluronic acid (HA). Eyedrops were administered 4 times daily for 3 months. The Ocular Surface Disease Index (OSDI) questionnaire, tear break-up time (TBUT), corneal and conjunctival staining, and meibomian gland assessment (MGD) were evaluated; furthermore, corneal aesthesiometry, in vivo corneal confocal microscopy, visual acuity, intraocular pressure (IOP), and fundus examination were performed. Results: At the end of treatment, OSDI score significantly decreased in groups A and B (p&lt;0.01 and p&lt;0.05, respectively); the decrease was significantly higher in group A. Corneal staining decreased in both groups, with lower scores in group A. The MGD was significantly ameliorated in group A patients. No differences were found for corneal aesthesiometry or TBUT. Epithelial cell reflectivity was significantly reduced only in group A. For keratocytes and stromal matrix parameters, there was a significant improvement in group A. No changes were found for visual acuity, IOP, or fundus examination. Conclusions: The XLHA + CoQ10 treatment showed greater effectiveness in DED compared to HA alone, probably due to the longer permanency on ocular surface and the antioxidant activity of CoQ10. Therefore, XLHA + CoQ10 eyedrops could represent a new possibility in dry eye treatment.</description><issn>1120-6721</issn><issn>1724-6016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptkMtKAzEUhoMoWKsrX-AsBZmaZCaZ6VJKvUBBBF0PaXLSpk6TkqTIuPLRnWqXrv6z-M7tI-Sa0YkoKbvDTZgIShll7ISMWM2rQlImT4eacVrImrNzcpHShlJOpxUfke-5tU4r3UOwgD2aGHYJdPBZOe_8CnQMKRWd8x9oYN2rbh-DdxqUdgaUNwOL_qvfIrwyCs5DjqjyoXM3BPqc4NPlNWxdZyAH2AaDUWUEE_vDwktyZlWX8OqYY_L-MH-bPRWLl8fn2f2i0GUjcmGtaLREYRojS26XQnArFJ9WFqvGLA2rayFKWWJtGa8sF5IZ2mjOG1sqJWU5Jrd_c38fimjbXXRbFfuW0fYgrx3ktUd5A33zRye1wnYT9tEPx_2L_gBXB3EH</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Postorino, Elisa I.</creator><creator>Rania, Laura</creator><creator>Aragona, Emanuela</creator><creator>Mannucci, Carmen</creator><creator>Alibrandi, Angela</creator><creator>Calapai, Gioacchino</creator><creator>Puzzolo, Domenico</creator><creator>Aragona, Pasquale</creator><general>SAGE Publications</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180101</creationdate><title>Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye</title><author>Postorino, Elisa I. ; Rania, Laura ; Aragona, Emanuela ; Mannucci, Carmen ; Alibrandi, Angela ; Calapai, Gioacchino ; Puzzolo, Domenico ; Aragona, Pasquale</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Postorino, Elisa I.</creatorcontrib><creatorcontrib>Rania, Laura</creatorcontrib><creatorcontrib>Aragona, Emanuela</creatorcontrib><creatorcontrib>Mannucci, Carmen</creatorcontrib><creatorcontrib>Alibrandi, Angela</creatorcontrib><creatorcontrib>Calapai, Gioacchino</creatorcontrib><creatorcontrib>Puzzolo, Domenico</creatorcontrib><creatorcontrib>Aragona, Pasquale</creatorcontrib><collection>CrossRef</collection><jtitle>European journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Postorino, Elisa I.</au><au>Rania, Laura</au><au>Aragona, Emanuela</au><au>Mannucci, Carmen</au><au>Alibrandi, Angela</au><au>Calapai, Gioacchino</au><au>Puzzolo, Domenico</au><au>Aragona, Pasquale</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye</atitle><jtitle>European journal of ophthalmology</jtitle><date>2018-01-01</date><risdate>2018</risdate><volume>28</volume><issue>1</issue><spage>25</spage><epage>31</epage><pages>25-31</pages><issn>1120-6721</issn><eissn>1724-6016</eissn><abstract>Purpose: Dry eye disease (DED) is a common condition causing substantial burden. A randomized, controlled, single-masked study was performed in 40 patients with mild to moderate DED to evaluate the efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10 (CoQ10). Methods: Enrolled subjects were divided into 2 groups: group A, treated with XLHA + CoQ10; and group B, treated with hyaluronic acid (HA). Eyedrops were administered 4 times daily for 3 months. The Ocular Surface Disease Index (OSDI) questionnaire, tear break-up time (TBUT), corneal and conjunctival staining, and meibomian gland assessment (MGD) were evaluated; furthermore, corneal aesthesiometry, in vivo corneal confocal microscopy, visual acuity, intraocular pressure (IOP), and fundus examination were performed. Results: At the end of treatment, OSDI score significantly decreased in groups A and B (p&lt;0.01 and p&lt;0.05, respectively); the decrease was significantly higher in group A. Corneal staining decreased in both groups, with lower scores in group A. The MGD was significantly ameliorated in group A patients. No differences were found for corneal aesthesiometry or TBUT. Epithelial cell reflectivity was significantly reduced only in group A. For keratocytes and stromal matrix parameters, there was a significant improvement in group A. No changes were found for visual acuity, IOP, or fundus examination. Conclusions: The XLHA + CoQ10 treatment showed greater effectiveness in DED compared to HA alone, probably due to the longer permanency on ocular surface and the antioxidant activity of CoQ10. Therefore, XLHA + CoQ10 eyedrops could represent a new possibility in dry eye treatment.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.5301/ejo.5001011</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1120-6721
ispartof European journal of ophthalmology, 2018-01, Vol.28 (1), p.25-31
issn 1120-6721
1724-6016
language eng
recordid cdi_crossref_primary_10_5301_ejo_5001011
source Sage Journals Online
title Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A19%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20eyedrops%20containing%20cross-linked%20hyaluronic%20acid%20and%20coenzyme%20Q10%20in%20treating%20patients%20with%20mild%20to%20moderate%20dry%20eye&rft.jtitle=European%20journal%20of%20ophthalmology&rft.au=Postorino,%20Elisa%20I.&rft.date=2018-01-01&rft.volume=28&rft.issue=1&rft.spage=25&rft.epage=31&rft.pages=25-31&rft.issn=1120-6721&rft.eissn=1724-6016&rft_id=info:doi/10.5301/ejo.5001011&rft_dat=%3Csage_cross%3E10.5301_ejo.5001011%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-ff58c6e5d8d632fb552f5a294fe48dbd17755363e7f124f2561d08c228f3aa663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_sage_id=10.5301_ejo.5001011&rfr_iscdi=true